Bicalutamide is a medicine used to manage prostate cancer. Limiting the effects of hormones prevents specific cells from receiving signals that encourage them to grow rapidly.
When prostate cells begin to grow faster than normal, many patients notice changes in urinary flow or pelvic discomfort. Bicalutamide belongs to a group called non-steroidal anti-androgens, which are medicines that interfere with the body’s male hormones. Its main purpose is to help manage hormone-driven prostate cancer by blocking the effect of testosterone on cancer cells. This active compound can be found in products that list Bicalutamide as the ingredient, such as the tablet form commonly prescribed in Singapore.
The drug works alongside other hormone-targeting treatments, offering a way to reduce disease progression without directly lowering testosterone levels. Because it is taken orally, patients usually receive it in a steady dose that fits into their overall cancer care plan. In Singapore, the medicine is regulated under the Health Sciences Authority, ensuring that each batch meets safety standards.
In practice, the name Bicalutamide appears on the label of several tablet preparations used for prostate cancer. These tablets are typically 50 mg or 150 mg in strength and are taken once daily. While brand names may differ, the generic version contains the same active ingredient and follows the same regulatory requirements in Singapore. The tablets are the most common form, though research formulations for injection exist, they are not part of standard care in the country.
Both branded and generic options are marketed as “Bicalutamide tablets.” The key difference lies in price and packaging, not in the chemical itself. Patients should check the medicine package to confirm that Bicalutamide is listed as the active ingredient.
For men diagnosed with advanced prostate cancer, hormone-responsive disease often needs a therapy that blocks male hormones. Bicalutamide medications are used to slow tumor growth in such cases. It is also added to treatment plans for metastatic prostate cancer, where the disease has spread beyond the prostate gland. Some clinicians may use the drug for hormone-sensitive male breast cancer, although this is less common. Generally, the medication is aimed at adults whose cancer cells rely on androgens to proliferate.
Bicalutamide works by attaching to androgen receptors on cells, preventing testosterone and similar hormones from binding. When these receptors stay blocked, the signal that tells cancer cells to grow is weakened. This simple blocking action can help keep the tumor from expanding as quickly, giving other treatments more time to work.
Mild nausea, fatigue, and occasional skin rashes are frequently reported by patients taking Bicalutamide tablets. Some individuals notice mild breast tenderness or hot flashes, which often improve with time.
Rarely, the drug can cause liver inflammation, severe allergic reactions, or significant changes in blood hormone levels. Sudden yellowing of the skin or eyes, intense itching, or swelling of the face should prompt immediate medical attention.
Pregnancy and breastfeeding are not applicable, as the medication is intended for adult men. Patients with known liver disease or a history of severe allergic reactions to similar compounds should avoid Bicalutamide unless a specialist advises otherwise.
Alcohol intake can increase the chance of liver irritation, and certain medicines that affect liver enzymes may change how Bicalutamide works. Readers should refer to their medication’s labeling or package insert for detailed interaction information.
When storing Bicalutamide tablets, keep them in a cool, dry place away from direct sunlight. Most treatment courses last several months, but the exact duration varies between different Bicalutamide products. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of Bicalutamide and is not medical advice. Medicines containing this active ingredient, such as Bicalutamide tablets, may differ in formulation, strength, and instructions. The information shared does not replace professional clinical judgment, and the author accepts no liability for any clinical decisions made. Readers should review the labeling of their specific medication and seek guidance from a healthcare professional for personalized advice.
For more details on Bicalutamide, you may consult the following resources:
